Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2006-06-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet Count Trends in Pre-eclamptic Parturients
NCT00787241
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855
Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development
NCT02639676
Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR
NCT00634855
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SGA infants
Infants who are thought to be small for gestational age (SGA)
Cord blood
Cord blood will be obtained at the time of delivery.
Pre-eclampsia exposed
Infants who are born to mothers who had pre-eclampsia
Cord blood
Cord blood will be obtained at the time of delivery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cord blood
Cord blood will be obtained at the time of delivery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants born to mothers with preeclampsia
* Infants who are born small for gestational age whose mother did not have preeclampsia
Exclusion Criteria
* Infants with known congenital anomalies or known congenital infections
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cardeza Foundation for Hematologic Research
OTHER
Christiana Care Health Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christiana Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelly Zook, MD
Role: PRINCIPAL_INVESTIGATOR
Christiana Care Health Systems; Thomas Jefferson University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christiana Care Health Systems
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCC# 26075
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.